Commentary: The uptake of human papillomavirus vaccination: the power of belief

of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model. BMC Public Health 2011;11:470. 29 Rondy M, van Lier A, van de Kassteele J, Rust L, de Melker H. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine 2010;28:2070–75. 30 Smith LM, Brassard P, Kwong JC, Deeks SL, Ellis AK, Levesque LE. Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls. BMC Public Health 2011;11:645. 31 Guerry SL, De Rosa CJ, Markowitz LE et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011;29:2235–41. 32 Rosenthal SL, Rupp R, Zimet GD et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008;43: 239–45. 33 Tan W, Viera AJ, Rowe-West B, Grimshaw A, Quinn B, Walter EB. The HPV vaccine: Are dosing recommendations being followed? Vaccine 2011;29:2548–54. 34 Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009;84:864–70. 35 Gold R, Naleway AL, Jenkins LL et al. Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon. Prev Med 2011;52:45658. 36 Niccolai LM, Mehta NR, Hadler JL. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. AJPM 2011;41:428–33. 37 Arbyn M, Castellsagué X, de Sanjosé S et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011;22: 2675–86. 38 Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med 2007;45:107–14. 39 McKinnon B, Harper S, Moore S. Decomposing incomerelated inequality in cervical screening in 67 countries. Int J Public Health 2011;56:139–52. 40 Teitelman AM, Stringer M, Nguyen GT, Hanlon AL, Averbuch T, Stimpfel AW. Social cognitive and clinical factors associated with HPV vaccine initiation among urban, economically disadvantaged women. J Obstet Gynecol Neonatal Nurs 2011;40:691–701. 41 Kessels SJM, Marshall HS, Watson M, BraunackMayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: A systematic review. Vaccine 2012;30:3546–56. 42 Cooper Robbins SC, Bernard D, McCaffery K, Brotherton JM, Skinner S. ‘‘I just signed’’: Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psychol 2010;29:618–25. 43 Gordon D, Waller J, Marlow LAV. Attitudes to HPV vaccination among mothers in the British Jewish community: Reasons for accepting or declining the vaccine. Vaccine 2011;29:7350–56. 44 Brown KF, Kroll JS, Hudson MJ et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: A systematic review. Vaccine 2010;28:4235–48. 45 Roberts KA, Dixon-Woods M, Fitzpatrick R, Abrams KR, Jones DR. Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence. Lancet 2002;360:1596–99. 46 Schluterman NH, Terplan M, Lydecker AD, Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine 2011;29: 3767–72.